Breast Cancer Research Program
Abrahamson PE, Gammon MD, Lund MJ, Britton JA, Marshall SW, Flagg EW, Porter PL, Brinton LA, Eley JW, Coates RJ. Recreational physical activity and survival among young women with breast cancer. Cancer. Sep 11[Epub ahead of print], 2006.
Aiello EJ, Buist DSM, White E. Do breast cancer risk factors modify the association between hormone therapy and breast density? Cancer Causes and Control (in press).
Alfano CM, McGregor BA, Kuniyuki A, Reeve B, Bowen DJ, Smith AW, Baumgartner K, Bernstein L, Ballard-Barbash R, Malone KE, Ganz P, McTiernan A. Psychometric Evaluation of the Brief Cancer Impact Assessment among breast cancer survivors. Oncology 70: 190-202, 2006.
Alfano CM, McGregor BA, Kuniyuki A, Reeve BR, Bowen DJ, Baumgartner KB, Bernstein L, Ballard-Barbash R, Malone KE, Ganz PA, McTiernan A. Psychometric properties of a tool for measuring hormone-related symptoms in breast cancer survivors. Psycho-oncology, in press, 2006.
Anderson BO, Shyyan R, Eniu AE, Smith RA, Yip C-H, Bese NS, Chow LWC, Masood S, Ramsey S, Carlson RW. Breast cancer in limited-resource countries: An overview of the Breast Health Global Initiative 2005 Guidelines. Breast J., 12(s1):s3-s15, 2006.
Anderson BO, Yip C-H, Ramsey S, Bengoa R, Braun S, Fitch M, Groot MT, Sancho-Garnier H, Tsu VD. Breast cancer in limited-resource countries: Health care systems and public policy. Breast J., 12(s1):s54-s69, 2006.
Anderson BO, Calhoun KE, Rosen EL. Evolving concepts in the management of lobular neoplasia. J. Natl. Compr. Canc. Netw., 4(5):511-12, 2006.
Anderson BO, Eniu AE, Sullivan LM, Carlson RW. Defining resource-level appropriate cancer control (Chapter 3). Report on the Breast Health Global Initiative prepared for the Institute of Medicine project on Cancer Control in Low- and Middle-Income Countries. National Academy Press, in press, 2006.
Anderson BO, Khalil EA. Breast conservation without mammography? Oncology practice in the real world of limited resource countries. Breast, in press, 2006.
Anderson BO. Breast health care and cancer control in limited resource countries: a framework for change. Nature Clinical Practice Oncology, 3(1):4-5, 2006.
Anderson BO. How many nodes are enough? The breast surgeon's dilemma. Ann. Surg. Oncol., 13(4): 439-441, 2006.
Ariail K, Watts CC, Bowen DJ. Retention in a breast cancer risk information trial: motivations of a population-based sample of women. Health Educ Behav. 33(5):591-603, 2006.
Balkwill FR, Ashworth A, Bast RC, et al. 10th Biennial Helene Harris Memorial Trust meeting. Cancer Res 2006; 66(6):2904-6.
Barlow WE, White E, Ballard-Barbash R, Vacek PM, Titus-Ernstoff LT, Carney PA, Tice JA, Buist DSM, Geller BM, Rosenberg R, Yankaskas BC, Kerlikowske K. A prospective breast cancer risk prediction model among women undergoing screening mammography. J Natl Cancer Inst 98:1204-14, 2006.
Bellew M, Coram M, Fitzgibbon M, Igra M, Randolph T, Wang P, May D, Eng J, Fang R, Lin C, Chen J, Goodlett D, Whiteaker J, Paulovich A, McIntosh M. A suite of algorithms for the comprehensive analysis of complex protein mixtures using high-resolution LC-MS. Bioinformatics June 9, 2006.
Benz CC, Fedele V, Xu F, et al. Altered promoter usage characterizes monoallelic transcription arising with ERBB2 amplification in human breast cancers. Genes Chromosomes Cancer 2006; 45(11):983-94.
Bernstein L, Patel AV, Ursin G, Sullivan-Halley J, Press MF, Deapen D, Berlin JA, Daling JR, McDonald JA, Norman SA, Malone KE, Strom BL, Liff J, Folger SG, Simon MS, Burkman RT, Marchbanks PA, Weiss LK, Spirtas R. Lifetime recreational exercise activity and breast cancer risk among black and white women. J Natl Cancer Inst 97: 1671-1679, 2005.
Bevers TB, Anderson BO, Bonaccio E, Borgen PI, Buys S, Daly MB, Dempsey PJ, Farrar WB, Fleming I, Garber JE, Harris RE, Helvie M, Hoover S, Krontiras H, Shaw S, Singletary E, Sugg Skinner C, Smith ML, Tsangaris TN, Wiley EL, Williams C. Breast cancer screening and diagnosis. J. Natl. Compr. Canc. Netw., 4(5):480-508, 2006.
Boudreau DM, Buist DSM, Rutter CM, Fishman PA, Beverly KR, Taplin S. Impact of hormone therapy on false positive recall rates and costs among women undergoing screening mammography. Medical Care 2006; 44:62-69.
Boudreau DM, Rutter CM, Buist DSM. Patterns of statin use and changes in breast density. Cancer Epidemiol Biomarkers Prev 2006;15:1026-9.
Bowen DJ, Burke W, Culver JO, Press N, Crystal S. Effects of counseling Ashkenazi Jewish women about breast cancer risk. Cultur Divers Ethnic Minor Psychol. 12(1):45-56, 2006.
Bowen DJ, Powers D, Greenlee H. Effects of breast cancer risk counseling for sexual minority women. Health Care Women Int. 27(1):59-74, 2006.
Buist DSM, Aiello EJ, Miglioretti DM, White E. Mammographic breast density, dense area and breast area by phase in the menstrual cycle. In Press: Cancer Epidemiol Biomarkers Prev.
Burch JB, Walling M, Rush A, Hennesey M, Craven W, Finlayson C, Anderson BO, Cosma G, Wells RL. Melatonin and estrogen in breast cyst fluids. Breast Cancer Res Treat, in press, 2006.
Calhoun KE, Anderson BO. Prophylactic mastectomy and the clinical management of high-risk breast cancer patients Community Oncol., 3(6):379-382, 2006.
Calhoun KE, Anderson BO. The changing paradigm of lobular neoplasia of the breast. Seminars in Breast Dis., in press, 2006.
Carney PA, Kerlikowske K, Yabroff KA, Abraham LA, Sickles EA, Tosteson ANA, Kasales CJ, Geller BM, Yankaskas BC, Rosenberg RD, Buist DSM, Dignan MB, Weaver DL, Miglioretti DL. Factors associated with imaging and procedural events used to detect breast cancer following screening mammography. In Press: Am J Roentgenology.
Chen C, Doherty JA, Lewis SK, Ray RM, Dao DL, Stalsberg H, Feng Z, Thomas DB. Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and the risk of fibrocystic breast conditions among Chinese women. Int. J. Cancer, 118: 2303-2309, 2006.
Chen C-Y, Calhoun KE, Masetti R, Anderson BO. Oncoplastic breast conserving surgery: A renaissance of anatomically-based surgical technique. Minerva Chirurgica, in press, 2006.
Chen C-Y, Sun LM, Anderson BO. Paget's disease of the breast: changing patterns of incidence, clinical presentation and treatment in the U.S. Cancer, in press, 2006.
Chien C, Li CI, Heckbert S, Malone KE, Boudreau DM, Daling JR. Antidepressant use and breast cancer risk. Breast Cancer Research and Treatment 95 (2): 131-140, 2006.
Crest AB, Aiello EJ, Anderson ML, Buist DSM. Varying levels of family history of breast cancer in relation to mammographic breast density. Ca Causes Control 2006;17:843-850.
Disis ML, dela Rosa C, Goodell V, et al. Maximizing the retention of antigen specific lymphocyte function after cryopreservation. J Immunol Methods 2006; 308(1-2):13-8.
Disis ML, Lyerly HK. Global role of the immune system in identifying cancer initiation and limiting disease progression. J Clin Oncol 2005; 23(35):8923-5.
Disis ML, Rivkin SE, Baron A, et al. Progress in ovarian cancer research: proceedings of the 5th Biennial Ovarian Cancer Research Symposium. Int J Gynecol Cancer 2006; 16(2):463-9.
Disis ML. Molecular targeting with cancer vaccines. J Clin Oncol 2005; 23(22):4840-1.
Dunnwald LK, Gralow JR, Ellis GK, Livingston RB, Linden HM, Lawton TJ, Barlow WE, Schubert EK, Mankoff DA. Residual uptake of [Tc-99m]-sestamibi after neoadjuvant chemotherapy for locally advanced breast cancer predicts survival. Cancer 103: 680-688, 2005.
Enger SM, Thwin SS, Buist DSM, Field T, Frost F, Geiger AM, Lash TL, Prout M, Ulcickas Yood M, Wei F, Silliman RA. Breast cancer treatment among older women in Integrated Health Care settings. In Press: J Clinical Oncology.
Eniu AE, Carlson RW, Aziz Z, Bines J, Hortobágyi G, Bese NS, Love RR, Vikram B, Kurkure K, Anderson BO. Breast cancer in limited-resource countries: Treatment and allocation of resources. Breast J., 12(s1):s38-s53, 2006.
Eubank WB and Mankoff DA. Evolving role of PET in breast cancer imaging. Sem Nucl Med 35: 84-99, 2005.
Falk RT, Brinton LA, Madigan P, Potischman N, Sturgeon SR, Malone KE, Daling JR. Interrelationships between serum leptin, IGF-1, IGFBP3, C-peptide, and prolactin and breast cancer risk in young women. Breast Cancer Research Treatment 98(2):157-165, 2006.
Gallardo M, Silva A, Rubio L, Alvarez C, Torrealba C, Salinas M, Tapia T, Faundez P, Palma L, Riccio ME, Paredes H, Rodriguez M, Cruz A, Rousseau C, King MC, Camus M, Alvarez M, Carvallo P. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations. Breast Cancer Res Treat 95(1):81-7, 2006.
Geller BM, Ichikawa L, Buist DSM, Sickles EA, Carney P, Yankaskas B, Dignan M, Kerlikowske K, Ballard-Barbash R, Yabroff KR. Barlow W, Rosenberg R. Improving the concordance of mammography assessment and management recommendations. In Press: Radiology.
Gonzalez A, White E, Kristal AR, Littman AJ. Calcium intake and 10-year weight change in middle-aged adults. J Am Dietetic Assoc 2006; 106: 1066-73.
Goodell V, Salazar LG, Urban N, et al. Antibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian cancer. J Clin Oncol 2006; 24(5):762-8.
Gramling R, Anthony D, Lowery J, Ballinger L, Ma D, Habbal R, Leighton N, Bowen D. Association between screening family medical history in general medical care and lower burden of cancer worry among women with a close family history of breast cancer. Genet Med. 2005 Nov-Dec;7(9):640-5.
Groot MT, Baltussen R, Uyl-de Groot CA, Anderson BO, Hortobagyi GN. Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia. Breast J., 12(1):s81-s90, 2006.
Haab BB, Paulovich AG, Anderson NL, Clark AM, Downing GJ, Hermjakob H, Labaer J, Uhlen M. A reagent resource to identify proteins and peptides of interest to the cancer community: A workshop report. Mol Cell Proteomics 2006:July 24.
Haas JS, Miglioretti DL, Geller B, Buist DSM, Nelson DE. Kerlikowske K, Carney PA, Dash S, Breslau ES, Ballard-Barbash R. Exposure to newspaper coverage about the potential harmful effects of hormone therapy following the Women's Health Initiative and changes in use. In Press: J Health Communication.
Hartwell L, Mankoff D, Paulovich A, Ramsey S, Swisher E. Cancer biomarkers: a systems approach. Nature Biotechnology 8:905-908, 2006.
Hass JS, Geller B, Miglioretti DL, Buist DS, Nelson DE, Kerlikowske K, Carney PA, Breslau ES, Dash S, Canales MK, Ballard-Barbash R. Changes in the newspaper coverage about hormone therapy with the release of new medical evidence. J Gen Intern Med 2006;21:304-9. Epub Feb 22 2006.
Helmes AW, Culver JO, Bowen DJ. Results of a randomized study of telephone versus in-person breast cancer risk counseling. Patient Educ Couns. 2006 Jan 18; [Epub ahead of print]
Kanne JP, Mankoff DA, Lawton TJ, Minoshima S, Livingston RB. Gastric linitis plastica from metastatic breast carcinoma: FDG and FES PET appearance. AJR Am J Roentgen, in press, 2006.
Kedar-Barnes I, Shiri-Sverdlov R, Dagan E, Tsabari S, Shohat M, Catane R, King MC, Lahad A, Levy-Lahad E. Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population. Proc Natl Acad Sci U S A. 103(10):3770-4, 2006.
Kelloff GJ, Hoffman JM, Johnson B, Scher HI, Siegel BA, Cheng EY, Cheson BD, O'shaughnessy J, Guyton KZ, Mankoff DA, Shankar L, Larson SM, Sigman CC, Schilsky RL, Sullivan DC. Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin Cancer Res 11:2785-808. 2005.
Kelloff GJ, Krohn KA, Weissleder R, Mankoff DA, Hoffman JM, Link JM, Guyton KZ, Collins JM, Eckelman WC, Scher EI, O"Shaughnessy J, Cheson BD, Sigman CC, Tatum JL, Mills GQ, Sullivan DC, Woodcock J. The progress and promise of molecular imaging probes in oncologic drug development. Clinical Cancer Res, 11: 7967-7985, 2005.
Knutson KL, Dang Y, Lu H, et al. IL-2 immunotoxin therapy modulates tumor-associated regulatory T cells and leads to lasting immune-mediated rejection of breast cancers in neu-transgenic mice. J Immunol 2006; 177(1):84-91.
Knutson KL, dela Rosa C, Disis ML. Laboratory analysis of T-cell immunity. Front Biosci 2006; 11:1932-44.
Knutson KL, Disis ML, Salazar LG. CD4 regulatory T cells in human cancer pathogenesis. Cancer Immunol Immunother 2006.
Knutson KL, Disis ML. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer Immunol Immunother 2005.
Knutson KL, Lu H, Stone B, et al. Immunoediting of cancers may lead to epithelial to mesenchymal transition. J Immunol 2006; 177(3):1526-33.
Knutson KL, Wagner W, Disis ML. Adoptive T cell therapy of solid cancers. Cancer Immunol Immunother 2006; 55(1):96-103.
Krohn KA, Mankoff DA, Muzi M, Link JM, Spence AM. True tracers: comparing FDG with glucose and FLT with thymmidine. Nucl Med Biol 32: 663-671, 2005.
Li CI, Daling JR, Malone KE, Bernstein L, Marchbanks PA, Liff JM, Strom BL, Simon MS, Press MF, McDonald JA, Ursin G, Burkman RT, Deapen D, Spirtas R. Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancer. Cancer Epidemiol Biomarker Prev;15:946-954, 2006.
Li CI, Daling JR, Malone KE. Interactions between body mass index and hormone therapy and postmenopausal breast cancer risk. Cancer Causes and Control 17(5): 695-703, 2006.
Li CI, Malone KE, Daling JR. The relationship between various measures of cigarette smoking and risk of breast cancer among women 65-79 years of age. Cancer Causes and Control 16(8): 975-985, 2005.
Li CI, Malone KE, Saltzman BS, Daling JR. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ. Cancer 106 (10): 2104-2112, 2006.
Li CI, Uribe DJ, Daling JR. Clinical and pathologic characteristics of different histologic types of breast cancer. Brit J Cancer 93:1046-1052, 2005.
Li CI. Clinical characteristics of different histological types of invasive breast cancer. Current Medical Literature: Breast Cancer18:33-39, 2006.
Linden HM, Krohn KA, Livingston RB, Mankoff DA. Monitoring targeted therapy: Is fluorodeoxyglucose uptake a marker of early response? Clin Cancer Res 12(19):5608-10, 2006.
Linden HM, Stekhova S, Link JM, Gralow JR, Livingston RB, Ellis GK, Peterson LM. Schubert EK, Dunnwald LK, Krohn KA, Mankoff DA. Quantitative fluoroestradiol (FES) PET imaging predicts response to endocrine treatment in breast cancer. J Clin Oncol 24: 2793-2799, 2006.
Lipovich L, King MC. Abundant novel transcriptional units and unconventional gene pairs on human chromosome 22. Genome Res 16(1):45-54, 2006.
Littman AJ, White E, Satia JA, Bowen D, Kristal AR. Reliability and validity of 2 single-item measures of psychosocial stress. Epidemiol 17, 398-403, 2006.
Malone KE, Daling JR, Doody DR, Hsu L, Bernstein L, Coates RJ, Marchbanks PA, Simon MS, McDonald JA, Norman SA, Strom BL, Burkman RT, Ursin G, Deapen D, Weiss LK, Folger S, Madeoy J, Friedrichsen D, Suter NM, Humphrey MC, Spirtas RA, Ostrander EA. Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in Caucasian and Africa-American women ages 35-64. Cancer Research 66 (16): 8297-8308, 2006.
Manjili MH, Arnouk H, Knutson KL, et al. Emergence of immune escape variant of mammary tumors that has distinct proteomic profile and a reduced ability to induce "danger signals". Breast Cancer Res Treat 2006; 96(3):233-41.
Mankoff DA and Dunnwald LK. Changes in glucose metabolism and blood flow following chemotherapy for breast cancer. PET Clinics 1:71-82, 2005.
Mankoff DA and Eubank WB. Current and future use of positron emission tomography (PET) in breast cancer. J Mammary Gland Biology and Neoplasia, in press, 2006.
Mankoff DA and Krohn KA. PET imaging of response and resistance to cancer therapy, in Teicher B, Drug Resistance In Cancer Totowa, NJ: Humana Press, 2006.
Mankoff DA, Shields AF, Krohn KA. PET imaging of cellular proliferation. Radiol Clin N Am, 43: 153 - 167, 2005.
Mankoff DA. Breast Cancer imaging revisited. Breast Cancer Research 7: 276-278 2005.
Mankoff DA. Radiotracer breast cancer imaging: beyond FDG and MIBI. Physica Medica, in press, 2006.
Miguel AC, Keane JF, Whiteaker J, Zhang H, and Paulovich A. Compression of LC/MS Proteomic Data. Proceedings of the 19th IEEE International Symposium on Computer-Based Medical Systems. CBMS, 2006.
Norman SA, Localio AR, Zhou L, Weber A, Coates R, Malone KE, Bernstein L, Marchbanks P, Lee N, Nadel M. Benefit of screening mammography in reducing the rate of late-stage breast cancer diagnosis. Cancer Causes and Control 17:921-929, 2006.
Piening BD, Wang P, Bangur CS, Whiteaker J, Zhang H, Feng L-C, Keane JF, Eng JK, Tang H, Prakash A, McIntosh MW, and Paulovich A. Quality control metrics for LC-MS feature detection tools demonstrated on Saccharomyces cerevisiae proteomic profiles. Journal of Proteome Research 5(7):1527-34, 2006.
Porter P, Barlow W, Yeh IT, Lin M-G, Yuan X, Donato E, Sledge G, Shapiro C, Ingle J, Haskell C, Albain K, Roberts J, Livingston R, and Hayes D. Cell cycle regulators p27 and cyclin E and breast cancer survival in 2123 women treated with doxorubicin and cyclophosphamide. JNCI, in press, 2006.
Prakash A, Mallick P, Whiteaker J, Zhang H, Paulovich A, Flory M, Lee H, Aebersold R and Schwikowski B. Signal maps for mass spectrometry-based comparative proteomics. Mol Cell Proteomics 5(3):423-32, 2005.
Puente XS, Velasco G, Gutierrez-Fernandez A, Bertranpetit J, King MC, Lopez-Otin C. Comparative analysis of cancer genes in the human and chimpanzee genomes. BMC Genomics 7(1):15, 2006.
Quillin JM, Ramakrishnan V, Borzelleca J, Bodurtha J, Bowen D, Baer Wilson D. Paternal relatives and family history of breast cancer. Am J Prev Med 31(3):265-8, 2006.
Rajendran JG, Hendrickson, KR, Spence AM, Muzi M, Krohn KA, Mankoff DA. Hypoxia imaging-directed radiation treatment planning. Eur J Nucl Med Mol Imag 33 Suppl 13, 44-53, 2006.
Rajendran JR and Mankoff DA. PET imaging of blood flow and hypoxia in tumors. in Shields AF and Price P, eds, In Vivo Imaging of Cancer, in press, 2006.
Rao K, Alper O, Opheim K, Bonnet G, Wolfe K, Bryant E, Larrivee S, Porter P, McDougall J. Cytogenetic characterization and H-ras associated transformation of immortalized human mammary epithelial cells. Cancer Cell Int. 6(1):15, 2006.
Rauch A, Bellew, M Eng J, Fitzgibbon M, Holzman T, Hussey P, Igra M, Maclean B, Lin C, Detter A, Fang R, Faca V, Gafken P, Zhang H, Whitaker J, States D, Hanash S, Paulovich A, McIntosh M. Computational Proteomics Analysis System (CPAS): An extensible open source analytic system for evaluating and publishing proteomic data and high throughput biological experiments. Journal of Proteome Research 5(1):112-21, 2006.
Rosenberg RD, Yankaskas BC, Abraham L, Sickles EA, Lehman C, Geller BM, Carney PA, Kerlikowske K, Buist D, Weaver D, Barlow WE. Ballard-Barbash R. Benchmarks for screening mammography. Radiology, in press, 2006.
Rosenblatt KA, Gao DL, Ray RM, Rowland MR, Nelson ZC, Wernli KJ, Li W, Thomas DB. Induced Abortions and the Risk of All Cancers Combined and Site-Specific Cancers in Shanghai. Cancer Causes and Control, in press, 2006.
Salazar LG, Disis ML. Cancer vaccines: the role of tumor burden in tipping the scale toward vaccine efficacy. J Clin Oncol 2005; 23(30):7397-8.
Shaag A, Walsh T, Renbaum P, Kirchhoff T, Nafa K, Shiovitz S, Mandell JB, Welcsh P, Lee MK, Ellis N, Offit K, Levy-Lahad E, King MC. Functional and genomic approaches reveal an ancient CHEK2 allele associated with breast cancer in the Ashkenazi Jewish population. Hum Mol Genet. 14(4):555-63, 2005.
Shahin H, Walsh T, Sobe T, Abu Sa'ed J, Abu Rayan A, Lynch ED, Lee MK, Avraham KB, King MC, Kanaan M. Mutations in a novel isoform of TRIOBP that encodes a filamentous-actin binding protein are responsible for DFNB28 recessive nonsyndromic hearing loss. Am J Hum Genet 78(1):144-52, 2006.
Shankar LK, Hoffman JM, Bacharach S, Graham MM, Karp J, Lammertsma, Larson S, Mankoff DA, Siegel B, Van den Abbeele A, Yap J, Sullivan D. Guidelines for the use of positron emission tomography (PET) and [18F]-2-fluoro-2-deoxy-d-glucose (FDG) as an indicator of therapeutic response in patients involved in National Cancer Institute (NCI) clinical trials. J Nucl Med 47: 1059-1055, 2006.
Simon MS, Korczak JF, Yee CL, Daling JR, Malone KE, Bernstein L, Marchbanks PA, Folger SG, McDonald JA, Norman SA, Strom BL, Deapen D, Ursin G, Burkman RT, Press MF, Schwartz AG, Spirtas R. Racial differences in the familial aggregation of breast cancer and other female cancers. Breast Cancer Research and Treatment 89:227-235, 2005.
Simon MS, Korczak JF, Yee CL, Malone KE, Ursin G, Bernstein L, McDonald JA, Deapen D, Strom BL, Press MF, Marchbanks PA, Burkman RT, Weiss L, Schwartz AG. Breast cancer risk estimates for relatives of Caucasian and African-American breast cancer cases in the Women's Contraceptive and Reproductive (CARE) Study. Journal of Clinical Oncology 24(16): 2498-2504, 2006.
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette M A, Paulovich A, Pomeroy S L, Golub TR, Lander E S and Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102, 15545-50, 2005.
Thompson JA, Dissanayake SK, Ksander BR, Knutson KL, Disis ML, Ostrand-Rosenberg S. Tumor cells transduced with the MHC class II Transactivator and CD80 activate tumor-specific CD4+ T cells whether or not they are silenced for invariant chain. Cancer Res 2006; 66(2):1147-54.
Tice JA, Kanaya A, Hue T, Rubin S, Buist DSM, LaCroix A, Lacey JV, Cauley J, Litwack S, Brinton LA, Bauer D. Risk factors for mortality in middle-aged women. Archives Intern Med, in press, 2006.
Trivers KF, Gammon MD, Abrahamson PE, Lund MJ, Flagg EW, Kaufman JS, Moorman PG, Cai J, Olshan AF, Porter PL, Brinton LA, Eley JW, Coates RJ. Association between reproductive factors and breast cancer survival in younger women. Breast Cancer Res Treat. Sep 27 [Epub ahead of print], 2006.
Vamre TB, Stalsberg H, Thomas DB, and the WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Extra-tumoral breast tissue in breast cancer patients: variations with steroid contraceptive use. Int J Cancer, 118 (11): 2827-31, 2006.
Velicer CM, Heckert SR, Rutter C, Lampe JW, Malone KE. Antibiotic use prior to breast cancer diagnosis is not associated with less favorable tumor characteristics. Cancer Causes and Control 17: 307-313, 2005.
Walsh T, Abu Rayan A, Abu Sa'ed J, Shahin H, Shepshelovich J, Lee MK, Hirschberg K, Tekin M, Salhab W, Avraham KB, King MC, Kanaan M. Genomic analysis of a heterogeneous Mendelian phenotype: multiple novel alleles for inherited hearing loss in the Palestinian population. Hum Genomics 2(4):203-11, 2006.
Walsh T, Casadei S, Coats KH, Swisher E, Stray SM, Higgins J, Roach KC, Mandell J, Lee MK, Ciernikova S, Foretova L, Soucek P, King MC. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA 295(12):1379-88, 2006.
Wang P, Tang H, Zhang H, Whiteaker J, Paulovich A, Mcintosh M. Normalization regarding non-random missing values in high-throughput mass spectrometry data. Proceedings of the Pacific Symposium, edited by Russ B Altman, Tiffany Murray, Teri E Klein (Stanford University, USA), A Keith Dunker (Indiana University, USA) & Lawrence Hunter (University of Colorado Health Sciences Center, USA), 2006.
Warner E, Morris E, Mankoff DA. Newer imaging modalities to diagnose breast cancer and guide its treatment. ASCO Education Book, 2006.
Wayne SJ, Baumgartner K, Baumgartner RN, Bernstein L, Bowen DJ, Ballard-Barbash R. Diet quality is directly associated with quality of life in breast cancer survivors. Breast Cancer Res Treat. 96(3):227-32, 2006.
Weaver DL, Rosenberg RD, Barlow WE, Ichikawa L, Carney PA, Kerlikowske K, Buist DSM, Geller BM, Key CR, Maygarden SJ, Ballard-Barbash R. Pathologic findings from the Breast Cancer Surveillance Consortium: Population-based outcomes in women undergoing biopsy after screening mammography. Cancer 106:732-742, 2006.
Wright AS, Anderson BO. Interactive clinical anatomy: axillary surgery CD-ROM (product review). Lancet Oncol., 7(9):716-717, 2006.
Yang J, Huston L, Berger D, et al. Expression of HLA-DP0401 molecules for identification of DP0401 restricted antigen specific T cells. J Clin Immunol 2005; 25(5):428-36.
Zhang H, Knutson KL, Hellstrom KE, Disis ML, Hellstrom I. Antitumor efficacy of CD137 ligation is maximized by the use of a CD137 single-chain Fv-expressing whole-cell tumor vaccine compared with CD137-specific monoclonal antibody infusion. Mol Cancer Ther 2006; 5(1):149-55.